Public Summary Documents by Meeting
PBAC Public Summary Documents - November 2009
Public summary documents relating to the November 2009 PBAC meeting
Agalsidase alfa (ghu) and beta (rch) infusions, literature review; Replagal®, Fabrazyme®, November 2009
Alglucosidase alfa, powder for I.V. infusion, 50 mg, Myozyme®, November 2009
Aprepitant, pack containing 1 capsule 125 mg and 2 capsules 80 mg, Emend®, November 2009
Botulinum toxin type A purified neurotoxin complex, lyophilised powder for I.M. injection, 100 units, Botox®, November 2009
Dabigatran etexilate mesilate, capsules, 75 mg and 110 mg (base), Pradaxa®, November 2009
Darunavir, tablets, 150 mg and 300 mg (as ethanolate), Prezista®, November 2009
Diclofenac sodium with misoprostol, tablet, 50 mg–200 micrograms, Arthrotec® 50, November 2009
Docetaxel, injection set containing 1 single use vial concentrate for I.V. infusion 20 mg (anhydrous) in 0.5 mL and 1 single use vial solvent 1.5 mL and injection set containing 1 single use vial concentrate for I.V. infusion 80 mg (anhydrous) in 2 mL and 1 single use vial solvent 6 mL, Taxotere®, November 2009
Dutasteride, capsule, 500 micrograms, Avodart®, November 2009
Everolimus, tablet, 5 mg and 10 mg, Afinitor®, November 2009
Ganirelix, solution for injection, 250 micrograms in 0.5ml (as acetate), single use pre-filled syringe, Orgalutran®, November 2009
Goserelin acetate, subcutaneous implant, 3.6 mg (base) in pre-filled injection syringe, Zoladex Implant®, November 2009
Imatinib, tablet, 100 mg and 400 mg (as mesylate), Glivec®, November 2009
Lacosamide, tablets, 50 mg, 100 mg, 150 mg and 200 mg, oral solution, 15 mg per mL, Vimpat®, November 2009
Maraviroc, tablets, 150 mg and 300 mg, Celsentri®, November 2009
Methoxy polyethylene glycol-epoetin beta, solution for injection, 30 micrograms in 0.3 mL, 50 micrograms in 0.3 mL, 75 micrograms in 0.3 mL, 100 micrograms in 0.3 mL, 120 micrograms in 0.3 mL, 200 micrograms in 0.3 mL and 360 micrograms in 0.6 mL, single use pre-filled syringe, Mircera®, November 2009
Nebivolol hydrochloride, tablets, titration pack containing 42 tablets 1.25mg and 14 tablets 5 mg, 1.25 mg, 5 mg and 10 mg (base), Nebilet®, November 2009
Omalizumab (rch), powder for injection, 150 mg, Xolair®, November 2009
Pemetrexed disodium, powder for I.V. infusion, 100 mg and 500 mg (base), Alimta®, November 2009
Rizatriptan benzoate, tablet, 5 mg and 10 mg (base), wafer, 5 mg and 10 mg (base), Maxalt®, November 2009
Tenofovir disoproxil fumarate with emtricitabine and efavirenz, tablet, 300 mg – 200 mg – 600 mg, Atripla®, November 2009
Tocilizumab, solution for I.V. infusion, 80 mg in 4 mL, 200 mg in 10 mL and 400 mg in 20 mL, Actemra® , November 2009
Ustekinumab (rmc), solution for injection, 45 mg in 0.5 mL, Stelara®, November 2009
Varenicline tartrate, tablet, 1 mg, Champix®, November 2009
Zoledronic acid, solution for I.V. infusion, 5 mg (as monohydrate) in 100 mL, Aclasta®, (Men), November 2009
Zoledronic acid, solution for I.V. infusion, 5 mg (as monohydrate) in 100 mL, Aclasta®, (CIO) November 2009
Zoledronic acid, solution for I.V. infusion, 5 mg (as monohydrate) in 100 mL, Aclasta®, (Paget), November 2009
Top of page
